Overview
Rh(D) typing uses anti-D reagents to detect D antigen expression on erythrocytes.
Clinical Importance
Assign RhD status for RBC selection and RhIG eligibility pathways
Confirm donor and patient RhD types
Specimen Requirements
- Specimen: whole blood (EDTA preferred for most typing, screens, and crossmatches)
- Tube: lavender/pink-top K₂EDTA (follow institutional blood bank tube color policy)
- Identity: two unique patient identifiers; many sites require a witnessed/type-and-screen collection process
- Handling: mix gently; do not use grossly hemolyzed specimens for serologic interpretation without investigation
- Timing: specimen age limits for pretransfusion testing are SOP-/standards-defined (commonly ≤3 days for patients who may have been transfused or pregnant recently; verify local AABB-aligned policy)
Analytical Method
Patient red cells are tested with monoclonal or blended anti-D reagents by tube, gel, or solid-phase methods. Immediate-spin or instrument-read reactions classify D+ or D−. Weak/partial D phenotypes may require weak D testing per policy.
Instruments Used
Automated analyzers
- Ortho Vision / Ortho Clinical Diagnostics automated immunohematology systems
- Bio-Rad IH-1000 / IH-500 and related gel/column systems
- Grifols Erytra / Wadiana automated blood typing systems
- Immucor NEO / Echo luminescent immunohematology systems
- Manual tube testing with centrifugation and macroscopic reading
- Column agglutination (gel/bead) card systems
- Solid-phase red cell adherence platforms
Manual methods
- Manual tube testing with immediate-spin and AHG phases as applicable
Reference Values
Immunohematology interpretations follow institutional SOPs aligned with AABB Standards, ISBT terminology, and applicable CLSI / BSH guidance. Reagent lots, method (tube, gel, solid-phase), and patient history critically affect results; always verify against the performing laboratory’s current procedure and applicable standards edition.
Expected categorical result: RhD positive or RhD negative per reagent reactivity. Method and reagent clone affect detection of weak/partial D.
Interpretation
Critical blood bank findings (e.g., ABO discrepancy blocking issue, positive crossmatch when blood is needed urgently, acute hemolytic transfusion reaction workup) follow institutional urgent-notification pathways. Confirm the local call list.
Critical values
- RhD mistyping can lead to unnecessary sensitization risk or inappropriate RhIG decisions
Common Causes of Increased Results
- Agglutination with anti-D . RhD positive (unless discrepancy/workup indicates otherwise)
Common Causes of Decreased Results
- No agglutination with anti-D . RhD negative by direct typing; weak D testing may still apply for selected patients/donors
Clinical Significance
- Pretransfusion testing
- Prenatal and postpartum RhIG pathways
- Donor unit labeling
Factors Affecting Results
Pre-analytical
- Patient misidentification or unlabeled/mislabeled specimens
- Wrong tube type or clotted EDTA specimen when plasma is required
- Specimen older than institutional pretransfusion dating limits
- IV fluid contamination or draw above an infusion
Analytical
- Reagent clone differences for partial D
- Mixed-field after transfusion of RhD-mismatched units
Post-analytical
- Reporting D− without following weak D policy for the patient category
Advantages and Limitations
Advantages
- Rapid, standardized antigen typing
Limitations
- Serology alone may miss some D variants
- Molecular RHD testing used when serology is inconclusive
Clinical Pearls
Not all anti-D reagents tell the same D story; know your clone when weak/partial D is on the table.
References
Authoritative textbooks, guidelines, and reviews supporting this laboratory test reference. Verify reference intervals, critical limits, and method details against institutional protocols and current guideline editions.
Textbooks
- Cohn CS, Delaney M, Johnson ST, Katz LM, eds. Technical Manual. 21st ed. AABB; 2023.
- Fung MK, Eder AF, Spitalnik SL, Westhoff CM, eds. Technical Manual. 20th ed. AABB; 2020.
- Harmening DM. Modern Blood Banking & Transfusion Practices. 7th ed. F.A. Davis; 2019.
- McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Elsevier; 2021.
- Bain BJ, Bates I, Laffan MA, eds. Dacie and Lewis Practical Haematology (verify current edition). Blood transfusion chapters.
CLSI and Professional Guidelines
- AABB. Standards for Blood Banks and Transfusion Services (verify current edition and institutional adoption).
- U.S. Food and Drug Administration. Code of Federal Regulations Title 21 . Blood and Blood Components (verify current institutional adoption).
- World Health Organization. Blood safety and availability / transfusion guidance (verify current WHO publication and institutional adoption).
- Clinical and Laboratory Standards Institute. Related immunohematology and specimen identity standards (verify current documents and institutional adoption).
- International Society of Blood Transfusion (ISBT). Blood group terminology and transfusion guidance (verify current ISBT publications).
- British Society for Haematology (BSH). Guidelines for blood grouping, antibody testing, and transfusion practice (verify current BSH guideline editions).
- Clinical and Laboratory Standards Institute. Immunohematology, specimen identification, and related transfusion laboratory documents (verify current CLSI editions).
WHO Publications
- World Health Organization. Blood safety, availability, and clinical transfusion guidance (verify current WHO publication).
Frequently Asked Questions
Common questions about using this Rh(D) Typing laboratory test Medical Laboratory Library reference in Medical Laboratory Science education.
What is the Rh(D) Typing laboratory test reference used for?
This Medical Laboratory Library page summarizes the clinical importance of Rh(D) Typing. Review the Clinical Importance section for why the test is ordered in laboratory medicine practice.
Where can I find Rh(D) Typing specimen requirements?
See the Specimen Requirements section on this page for specimen information related to Rh(D) Typing. Confirm collection details against your laboratory protocol.
Where are Rh(D) Typing reference values listed?
See the Reference Values section on this Laboratory Library page. Reference ranges can vary by method and population, so verify intervals with your laboratory.
How do I interpret Rh(D) Typing results?
Use the Interpretation section for laboratory interpretation framing, including increased and decreased result patterns when provided. Do not treat educational text as a patient-specific diagnosis.
What analytical method is used for Rh(D) Typing?
See the Analytical Method section for principle and method notes. Method details may differ by instrument and institutional SOP.
Are related laboratory tests linked from Rh(D) Typing?
Yes. The Related Laboratory Tests section lists connected references for continued lookup in the Medical Laboratory Library.
How can I continue learning after reading Rh(D) Typing?
Use Continue learning links on this page for related Academy lessons, medical laboratory quizzes, or laboratory case studies when available for this Blood Bank / Transfusion Medicine topic.
What are the clinical pearls for Rh(D) Typing?
See the Clinical Pearls section for concise laboratory practice notes associated with Rh(D) Typing. Apply pearls alongside institutional protocols.
Reading progress
Awards XP once after you have meaningfully reviewed this article.